Telomir Pharmaceuticals Files 8-K
Ticker: TELO · Form: 8-K · Filed: Jan 7, 2025 · CIK: 1971532
Sentiment: neutral
Topics: corporate-update, filing
TL;DR
Telomir Pharma updated its address and contact info in an 8-K filing on Jan 7, 2025.
AI Summary
On January 7, 2025, Telomir Pharmaceuticals, Inc. filed an 8-K report. The filing indicates that the company is located at 100 SE 2nd St, Suite 2000, #1009, Miami, Florida, 33131, and its principal executive offices are also at this address. The company's telephone number is (786) 396-6723.
Why It Matters
This filing provides updated corporate information and addresses for Telomir Pharmaceuticals, Inc., which is important for investors and stakeholders to have the most current contact and location details.
Risk Assessment
Risk Level: low — The filing is a routine corporate update and does not contain information about significant financial events, mergers, or regulatory actions.
Key Players & Entities
- Telomir Pharmaceuticals, Inc. (company) — Registrant
- 100 SE 2nd St, Suite 2000, #1009 Miami, Florida, 33131 (location) — Principal Executive Offices
- January 7, 2025 (date) — Date of Report
- (786) 396-6723 (phone_number) — Registrant's telephone number
FAQ
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is TELOMIR PHARMACEUTICALS, INC.
In which state was Telomir Pharmaceuticals, Inc. incorporated?
Telomir Pharmaceuticals, Inc. was incorporated in Florida.
What is the IRS Employer Identification Number for Telomir Pharmaceuticals, Inc.?
The IRS Employer Identification Number for Telomir Pharmaceuticals, Inc. is 87-2606031.
What is the address of Telomir Pharmaceuticals, Inc.'s principal executive offices?
The address of Telomir Pharmaceuticals, Inc.'s principal executive offices is 100 SE 2nd St, Suite 2000, #1009, Miami, Florida.
What is the telephone number of Telomir Pharmaceuticals, Inc.?
The telephone number of Telomir Pharmaceuticals, Inc. is (786) 396-6723.
Filing Stats: 681 words · 3 min read · ~2 pages · Grade level 14.4 · Accepted 2025-01-07 07:30:18
Filing Documents
- form8-k.htm (8-K) — 37KB
- 0001493152-25-001112.txt ( ) — 209KB
- telo-20250107.xsd (EX-101.SCH) — 3KB
- telo-20250107_lab.xml (EX-101.LAB) — 33KB
- telo-20250107_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TELOMIR PHARMACUTICALS, INC. Dated: January 7, 2025 By: /s/ Erez Aminov Name: Erez Aminov Title: Chief Executive Officer